Bio-Rad Laboratories BIO
NYSE BIO
$368.86 -8.11 (-2.15%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017)

Bio-Rad Laboratories' (BIO) quarterly Deferred Taxes came in at -$5.3 million in Q3 2017, down 142.66% year-over-year from $12.5 million in Q3 2016, and down 284.83% quarter-over-quarter from $2.9 million in Q2 2017.

Analysis

Bio-Rad Laboratories (BIO) Deferred Taxes (2015 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Deferred Taxes for 3 consecutive years, with -$5.3 million the latest figure, recorded in Q3 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn -208.00 Mn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn -
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn 20.00 Mn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn -21.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn -
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn 5.15 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn -
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn 2.93 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn -
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.35 Mn
Jun 30, 2017 2.89 Mn
Mar 31, 2017 163,000.00
Sep 30, 2016 12.54 Mn
Jun 30, 2016 -666,000.00
Mar 31, 2016 -3.39 Mn
Sep 30, 2015 -2.73 Mn